Inhibition of RAS in diabetic nephropathy

References

• YacoubRLeeKHeJCThe role of SIRT1 in diabetic kidney diseaseFront Endocrinol20145166
   PubMed Web of Science ®Google Scholar
• FoxCSPencinaMJMeigsJBVasanRSLevitzkyYSD’AgostinoRBSrTrends in the incidence of type 2 diabetes mellitus from the 1970s to the 1990s: the Framingham Heart StudyCirculation2006113252914291816785337
   PubMed Web of Science ®Google Scholar
• HuDFuPXieJIncreasing prevalence and low awareness, treatment and control of diabetes mellitus among Chinese adults: the InterASIA studyDiabetes Res Clin Pract200881225025718495287
   PubMed Web of Science ®Google Scholar
• XuYWangLHeJPrevalence and control of diabetes in Chinese adultsJAMA2013310994895924002281
   PubMed Web of Science ®Google Scholar
• TervaertTWMooyaartALAmannKPathologic classification of diabetic nephropathyJ Am Soc Nephrol201021455656320167701
   PubMed Web of Science ®Google Scholar
• MauerMZinmanBGardinerRRenal and retinal effects of enalapril and losartan in type 1 diabetesN Engl J Med20093611405119571282
   PubMed Web of Science ®Google Scholar
• BojestigMArnqvistHJHermanssonGKarlbergBELudvigssonJDeclining incidence of nephropathy in insulin-dependent diabetes mellitusN Engl J Med1994330115188259139
   PubMed Web of Science ®Google Scholar
• NguyenGMullerDNThe biology of the (pro)renin receptorJ Am Soc Nephrol2010211182319917780
   PubMed Web of Science ®Google Scholar
• KrolewskiASGenetics of diabetic nephropathy: evidence for major and minor gene effectsKidney Int19995541582159610201028
   PubMed Web of Science ®Google Scholar
• TrevisanRVibertiGGenetic factors in the development of diabetic nephropathyJ Lab Clin Med199512643423497561441
   PubMed Web of Science ®Google Scholar
• SatkoSGLangefeldCDDaeihaghPBowdenDWRichSSFreedmanBINephropathy in siblings of African Americans with overt type 2 diabetic nephropathyAm J Kidney Dis200240348949412200799
   PubMed Web of Science ®Google Scholar
• JeffersBWEstacioRORaynoldsMVSchrierRWAngiotensin-converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus and its relationship with diabetic nephropathyKidney Int19975224734779264004
   PubMed Web of Science ®Google Scholar
• YoshidaHKuriyamaSAtsumiYAngiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitusKidney Int19965026576648840299
   PubMed Web of Science ®Google Scholar
• KuramotoNIizukaTItoHEffect of ACE gene on diabetic nephropathy in NIDDM patients with insulin resistanceAm J Kidney Dis199933227628110023638
   PubMed Web of Science ®Google Scholar
• BorightAPPatersonADMireaLGenetic variation at the ACE gene is associated with persistent microalbuminuria and severe nephropathy in type 1 diabetes: the DCCT/EDIC Genetics StudyDiabetes20055441238124415793268
   PubMed Web of Science ®Google Scholar
• HadjadjSTarnowLForsblomCAssociation between angiotensin-converting enzyme gene polymorphisms and diabetic nephropathy: case-control, haplotype, and family-based study in three European populationsJ Am Soc Nephrol20071841284129117376814
   PubMed Web of Science ®Google Scholar
• KunzRBorkJPFritscheLRingelJSharmaAMAssociation between the angiotensin-converting enzyme-insertion/deletion polymorphism and diabetic nephropathy: a methodologic appraisal and systematic reviewJ Am Soc Nephrol199899165316639727374
   PubMed Web of Science ®Google Scholar
• Pettersson-FernholmKFrojdoSFageruddJThe AT2 gene may have a gender-specific effect on kidney function and pulse pressure in type I diabetic patientsKidney Int200669101880188416598200
   PubMed Web of Science ®Google Scholar
• PalmerBFRenal dysfunction complicating the treatment of hypertensionN Engl J Med2002347161256126112393824
   PubMed Web of Science ®Google Scholar
• BadrKFIchikawaIPrerenal failure: a deleterious shift from renal compensation to decompensationN Engl J Med1988319106236293045546
   PubMed Web of Science ®Google Scholar
• BakrisGLSlataperRVicknairNSadlerRACE inhibitor mediated reductions in renal size and microalbuminuria in normotensive, diabetic subjectsJ Diabetes Complications199481268167383
   PubMed Web of Science ®Google Scholar
• AbueloJGNormotensive ischemic acute renal failureN Engl J Med2007357879780517715412
   PubMed Web of Science ®Google Scholar
• HirschbergRBrunoriGKoppleJDGulerHPEffects of insulin-like growth factor I on renal function in normal menKidney Int19934323873978441234
   PubMed Web of Science ®Google Scholar
• AndersonSVoraJPCurrent concepts of renal hemodynamics in diabetesJ Diabetes Complications1995943043078573753
   PubMed Web of Science ®Google Scholar
• VlassaraHProtein glycation in the kidney: role in diabetes and agingKidney Int1996496179518048743500
   PubMed Web of Science ®Google Scholar
• HannedoucheTPDelgadoAGGnionsaheDABoitardCLacourBGrunfeldJPRenal hemodynamics and segmental tubular reabsorption in early type 1 diabetesKidney Int1990374112611332188030
   PubMed Web of Science ®Google Scholar
• VallonVRichterKBlantzRCThomsonSOsswaldHGlomerular hyperfiltration in experimental diabetes mellitus: potential role of tubular reabsorptionJ Am Soc Nephrol199910122569257610589696
   PubMed Web of Science ®Google Scholar
• YanagawaNPotential role for local luminal angiotensin II in proximal tubule sodium transportKidney Int Suppl199132S33S361881047
   PubMed Web of Science ®Google Scholar
• DentonKMFennessyPAAlcornDAndersonWPMorphometric analysis of the actions of angiotensin II on renal arterioles and glomeruliAm J Physiol19922623 Pt 2F367F3721558155
   PubMed Web of Science ®Google Scholar
• StahlRAParaviciniMSchollmeyerPAngiotensin II stimulation of prostaglandin E2 and 6-keto-F1 alpha formation by isolated human glomeruliKidney Int198426130346592393
   PubMed Web of Science ®Google Scholar
• OliverJAPintoJSciaccaRRCannonPJIncreased renal secretion of norepinephrine and prostaglandin E2 during sodium depletion in the dogJ Clin Invest19806647487566999033
   PubMed Web of Science ®Google Scholar
• VallottonMBGerber-WichtCDolciWWuthrichRPInteraction of vasopressin and angiotensin II in stimulation of prostacyclin synthesis in vascular smooth muscle cellsAm J Physiol19892575 Pt 1E617E6242512814
   PubMed Web of Science ®Google Scholar
• IchikawiIHarrisRCAngiotensin actions in the kidney: renewed insight into the old hormoneKidney Int19914045835961745006
   PubMed Web of Science ®Google Scholar
• BrennerBMCooperMEde ZeeuwDEffects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathyN Engl J Med20013451286186911565518
   PubMed Web of Science ®Google Scholar
• No authors listedEffects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study InvestigatorsLancet2000355920025325910675071
   PubMed Web of Science ®Google Scholar
• ACEInhibitors in Diabetic Nephropathy Trialist GroupShould all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient dataAnn Intern Med2001134537037911242497
   PubMed Web of Science ®Google Scholar
• PriceDAPorterLEGordonMThe paradox of the low-renin state in diabetic nephropathyJ Am Soc Nephrol199910112382239110541298
   PubMed Web of Science ®Google Scholar
• GurleySBCoffmanTMThe renin-angiotensin system and diabetic nephropathySemin Nephrol200727214415217418683
   PubMed Web of Science ®Google Scholar
• LuetscherJAKraemerFBWilsonDMSchwartzHCBryer-AshMIncreased plasma inactive renin in diabetes mellitus. A marker of microvascular complicationsN Engl J Med198531222141214173887168
   PubMed Web of Science ®Google Scholar
• LaiKNLeungJCLaiKBToWYYeungVTLaiFMGene expression of the renin-angiotensin system in human kidneyJ Hypertens1998161911029533422
   PubMed Web of Science ®Google Scholar
• TuckMLSambhiMPLevinLHyporeninemic hypoaldosteronism in diabetes mellitus. Studies of the autonomic nervous system’s control of renin releaseDiabetes1979283237241446908
   PubMed Web of Science ®Google Scholar
• KaneshiroYIchiharaASakodaMSlowly progressive, angiotensin II-independent glomerulosclerosis in human (pro)renin receptor-transgenic ratsJ Am Soc Nephrol20071861789179517494887
   PubMed Web of Science ®Google Scholar
• PetersBGriskOBecherBDose-dependent titration of prorenin and blood pressure in Cyp1a1ren-2 transgenic rats: absence of prorenin-induced glomerulosclerosisJ Hypertens200826110210918090546
   PubMed Web of Science ®Google Scholar
• ZimpelmannJKumarDLevineDZEarly diabetes mellitus stimulates proximal tubule renin mRNA expression in the ratKidney Int20005862320233011115066
   PubMed Web of Science ®Google Scholar
• HsiehTJZhangSLFilepJGTangSSIngelfingerJRChanJSHigh glucose stimulates angiotensinogen gene expression via reactive oxygen species generation in rat kidney proximal tubular cellsEndocrinology200214382975298512130563
   PubMed Web of Science ®Google Scholar
• ChoiKCKimNHAnMRKangDGKimSWLeeJAlterations of intrarenal renin-angiotensin and nitric oxide systems in streptozotocin-induced diabetic ratsKidney Int Suppl199760S23S279285898
   PubMed Web of Science ®Google Scholar
• HollenbergNKDirect renin inhibition and the kidneyNat Rev Nephrol201061495519935744
   PubMed Web of Science ®Google Scholar
• HuangYWongamornthamSKastingJRenin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanismsKidney Int200669110511316374430
   PubMed Web of Science ®Google Scholar
• HuangYNobleNAZhangJXuCBorderWARenin-stimulated TGF-beta1 expression is regulated by a mitogen-activated protein kinase in mesangial cellsKidney Int2007721455217396111
   PubMed Web of Science ®Google Scholar
• SakodaMIchiharaAKaneshiroY(Pro)renin receptor-mediated activation of mitogen-activated protein kinases in human vascular smooth muscle cellsHypertens Res200730111139114618250563
   PubMed Web of Science ®Google Scholar
• KaneshiroYIchiharaATakemitsuTIncreased expression of cyclooxygenase-2 in the renal cortex of human prorenin receptor gene-transgenic ratsKidney Int200670464164616807542
   PubMed Web of Science ®Google Scholar
• FeldtSBatenburgWWMazakIProrenin and renin-induced extracellular signal-regulated kinase 1/2 activation in monocytes is not blocked by aliskiren or the handle-region peptideHypertension200851368268818212269
   PubMed Web of Science ®Google Scholar
• MercureCPrescottGLacombeMJSilversidesDWReudelhuberTLChronic increases in circulating prorenin are not associated with renal or cardiac pathologiesHypertension20095361062106919364992
   PubMed Web of Science ®Google Scholar
• DanserAH(Pro)renin receptor and vacuolar H+-ATPaseHypertension200954221922119546373
   PubMed Web of Science ®Google Scholar
• AdvaniAKellyDJCoxAJThe (Pro)renin receptor: site-specific and functional linkage to the vacuolar H+-ATPase in the kidneyHypertension200954226126919546380
   PubMed Web of Science ®Google Scholar
• AndersonSJungFFIngelfingerJRRenal renin-angiotensin system in diabetes: functional, immunohistochemical, and molecular biological correlationsAm J Physiol19932654 Pt 2F477F4868238377
   PubMed Web of Science ®Google Scholar
• HuangYBorderWANobleNAFunctional renin receptors in renal mesangial cellsCurr Hypertens Rep20079213313917442225
   PubMed Web of Science ®Google Scholar
• NguyenGDelarueFBerrouJRondeauESraerJDSpecific receptor binding of renin on human mesangial cells in culture increases plasminogen activator inhibitor-1 antigenKidney Int1996506189719038943472
   PubMed Web of Science ®Google Scholar
• NguyenGDelarueFBurckleCBouzhirLGillerTSraerJDPivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to reninJ Clin Invest2002109111417142712045255
   PubMed Web of Science ®Google Scholar
• DurvasulaRVShanklandSJActivation of a local renin angiotensin system in podocytes by glucoseAm J Physiol Renal Physiol20082944F830F83918216149
   PubMed Web of Science ®Google Scholar
• LiuFYCoganMGAngiotensin II stimulates early proximal bicarbonate absorption in the rat by decreasing cyclic adenosine monophosphateJ Clin Invest198984183912544631
   PubMed Web of Science ®Google Scholar
• LiuFYCoganMGRole of protein kinase C in proximal bicarbonate absorption and angiotensin signalingAm J Physiol19902584 Pt 2F927F9332330986
   PubMed Web of Science ®Google Scholar
• KiforIMooreTJFalloFPotassium-stimulated angiotensin release from superfused adrenal capsules and enzymatically dispersed cells of the zona glomerulosaEndocrinology199112928238311855477
   PubMed Web of Science ®Google Scholar
• SinghRAlaviNSinghAKLeeheyDJRole of angiotensin II in glucose-induced inhibition of mesangial matrix degradationDiabetes199948102066207310512375
   PubMed Web of Science ®Google Scholar
• MezzanoSARuiz-OrtegaMEgidoJAngiotensin II and renal fibrosisHypertension2001383 Pt 263563811566946
   PubMed Web of Science ®Google Scholar
• WadaJMakinoHInflammation and the pathogenesis of diabetic nephropathyClin Sci2013124313915223075333
   PubMed Web of Science ®Google Scholar
• VellosoLAFolliFPeregoLSaadMJThe multi-faceted cross-talk between the insulin and angiotensin II signaling systemsDiabetes Metab Res Rev20062229810716389635
   PubMed Web of Science ®Google Scholar
• TiwariSHalagappaVKRiaziSHuXEcelbargerCAReduced expression of insulin receptors in the kidneys of insulin-resistant ratsJ Am Soc Nephrol200718102661267117855644
   PubMed Web of Science ®Google Scholar
• GloyJHengerAFischerKGAngiotensin II modulates cellular functions of podocytesKidney Int Suppl199867S168S1709736279
   PubMed Web of Science ®Google Scholar
• GarridoAMGriendlingKKNADPH oxidases and angiotensin II receptor signalingMol Cell Endocrinol2009302214815819059306
   PubMed Web of Science ®Google Scholar
• HaradaEYoshimuraMYasueHAldosterone induces angiotensin-converting-enzyme gene expression in cultured neonatal rat cardiocytesCirculation2001104213713911447075
   PubMed Web of Science ®Google Scholar
• KangYSKoGJLeeMHEffect of eplerenone, enalapril and their combination treatment on diabetic nephropathy in type II diabetic ratsNephrol Dial Transplant2009241738418682491
   PubMed Web of Science ®Google Scholar
• HanSYKimCHKimHSSpironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic ratsJ Am Soc Nephrol20061751362137216571782
   PubMed Web of Science ®Google Scholar
• MiyataKRahmanMShokojiTAldosterone stimulates reactive oxygen species production through activation of NADPH oxidase in rat mesangial cellsJ Am Soc Nephrol200516102906291216135774
   PubMed Web of Science ®Google Scholar
• SowersJRWhaley-ConnellAEpsteinMNarrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertensionAnn Intern Med20091501177678319487712
   PubMed Web of Science ®Google Scholar
• DonoghueMHsiehFBaronasEA novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1–9Circ Res2000875E1E910969042
   PubMed Web of Science ®Google Scholar
• CareyRMSiragyHMThe intrarenal renin-angiotensin system and diabetic nephropathyTrends Endocrinol Metab200314627428112890592
   PubMed Web of Science ®Google Scholar
• CrackowerMASaraoROuditGYAngiotensin-converting enzyme 2 is an essential regulator of heart functionNature2002417689182282812075344
   PubMed Web of Science ®Google Scholar
• MoriJPatelVBRamprasathTAngiotensin 1-7 mediates renoprotection against diabetic nephropathy by reducing oxidative stress, inflammation, and lipotoxicityAm J Physiol Renal Physiol20143068F812F82124553436
   PubMed Web of Science ®Google Scholar
• ZhangKMengXLiDAngiotensin(1-7) attenuates the progression of streptozotocin-induced diabetic renal injury better than angiotensin receptor blockadeKidney Int201587235936925075768
   PubMed Web of Science ®Google Scholar
• MiyataNParkFLiXFCowleyAWJrDistribution of angiotensin AT1 and AT2 receptor subtypes in the rat kidneyAm J Physiol19992773 Pt 2F437F44610484527
   PubMedGoogle Scholar
• OzonoRWangZQMooreAFInagamiTSiragyHMCareyRMExpression of the subtype 2 angiotensin (AT2) receptor protein in rat kidneyHypertension1997305123812469369282
   PubMed Web of Science ®Google Scholar
• ArimaSItoSAngiotensin II type 2 receptors in the kidney: evidence for endothelial-cell-mediated renal vasodilatationNephrol Dial Transplant200015444845110727534
   PubMed Web of Science ®Google Scholar
• OhBHMitchellJHerronJRChungJKhanMKeefeDLAliskiren, an oral renin inhibitor, provides dose-dependent efficacy and sustained 24-hour blood pressure control in patients with hypertensionJ Am Coll Cardiol200749111157116317367658
   PubMed Web of Science ®Google Scholar
• NichollsSJBakrisGLKasteleinJJEffect of aliskiren on progression of coronary disease in patients with prehypertension: the AQUARIUS randomized clinical trialJAMA2013310111135114423999933
   PubMed Web of Science ®Google Scholar
• ErdosEGMarcicBMKinins, receptors, kininases and inhibitors – where did they lead us?Biol Chem20013821434711258670
   PubMed Web of Science ®Google Scholar
• SironiLNobiliEGianellaAGelosaPTremoliEAnti-inflammatory properties of drugs acting on the renin-angiotensin systemDrugs Today200541960962216341292
   PubMed Web of Science ®Google Scholar
• KothariSALeMKGandhiPJEffects of angiotensin converting enzyme inhibitors on thrombotic mediators: potential clinical implicationsJ Thromb Thrombolysis200315321722514739632
   PubMed Web of Science ®Google Scholar
• NeutelJMEffect of the renin–angiotensin system on the vessel wall: using ACE inhibition to improve endothelial functionJ Hum Hypertens200418959960615190263
   PubMed Web of Science ®Google Scholar
• KlingbeilAUSchneiderMMartusPMesserliFHSchmiederREA meta-analysis of the effects of treatment on left ventricular mass in essential hypertensionAm J Med20031151414612867233
   PubMed Web of Science ®Google Scholar
• HilgersKFMannJFACE inhibitors versus AT(1) receptor antagonists in patients with chronic renal diseaseJ Am Soc Nephrol20021341100110811912272
   PubMed Web of Science ®Google Scholar
• MaJNishimuraHFogoAKonVInagamiTIchikawaIAccelerated fibrosis and collagen deposition develop in the renal interstitium of angiotensin type 2 receptor null mutant mice during ureteral obstructionKidney Int19985349379449551401
   PubMed Web of Science ®Google Scholar
• MorrisseyJJKlahrSEffect of AT2 receptor blockade on the pathogenesis of renal fibrosisAm J Physiol19992761 Pt 2F39F459887078
   PubMedGoogle Scholar
• CouserWGRiellaMCJoint International Society of Nephrology and International Federation of Kidney Foundations’ World Kidney Day Steering CommitteeWorld Kidney Day 2011: protect your kidneys, save your heartKidney Int201179548348521321555
   PubMed Web of Science ®Google Scholar
• American Diabetes AssociationDiabetic nephropathyDiabetes Care199821S50S53
   Web of Science ®Google Scholar
• Arauz-PachecoCParrottMARaskinPAmerican Diabetes AssociationTreatment of hypertension in adults with diabetesDiabetes Care200326Suppl 1S80S8212502624
   PubMedGoogle Scholar
• KDOQIKDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney diseaseAm J Kidney Dis2007492 Suppl 2S12S15417276798
   PubMed Web of Science ®Google Scholar
• KlahrSLeveyASBeckGJThe effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of diet in Renal Disease Study GroupN Engl J Med1994330138778848114857
   PubMed Web of Science ®Google Scholar
• PetersonJCAdlerSBurkartJMBlood pressure control, proteinuria, and the progression of renal disease. The modification of diet in renal disease studyAnn Intern Med1995123107547627574193
   PubMed Web of Science ®Google Scholar
• SarnakMJGreeneTWangXThe effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease studyAnn Intern Med2005142534235115738453
   PubMed Web of Science ®Google Scholar
• WrightJTJrBakrisGGreeneTEffect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trialJAMA2002288192421243112435255
   PubMed Web of Science ®Google Scholar
• AppelLJWrightJTJrGreeneTIntensive blood-pressure control in hypertensive chronic kidney diseaseN Engl J Med20103631091892920818902
   PubMed Web of Science ®Google Scholar
• JafarTHStarkPCSchmidCHProgression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysisAnn Intern Med2003139424425212965979
   PubMed Web of Science ®Google Scholar
• BakrisGLWeirMRShanifarSEffects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL studyArch Intern Med2003163131555156512860578
   PubMed Web of Science ®Google Scholar
• PohlMABlumenthalSCordonnierDJIndependent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitationsJ Am Soc Nephrol200516103027303716120823
   PubMed Web of Science ®Google Scholar
• RuzickaMQuinnRRMcFarlanePCanadian Society of Nephrology commentary on the 2012 KDIGO clinical practice guideline for the management of blood pressure in CKDAm J Kidney Dis201463686988724725980
   PubMed Web of Science ®Google Scholar
• TalerSJAgarwalRBakrisGLKDOQI US commentary on the 2012 KDIGO clinical practice guideline for management of blood pressure in CKDAm J Kidney Dis201362220121323684145
   PubMed Web of Science ®Google Scholar
• VerbekeFLindleyEVan BortelLA European Renal Best Practice (ERBP) position statement on the Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline for the management of blood pressure in non-dialysis-dependent chronic kidney disease: an endorsement with some caveats for real-life applicationNephrol Dial Transplant201429349049624071661
   PubMed Web of Science ®Google Scholar
• RobertsMACommentary on the KDIGO clinical practice guideline for the management of blood pressure in chronic kidney diseaseNephrology2014191535524341660
   PubMed Web of Science ®Google Scholar
• LewisEJHunsickerLGBainRPRohdeRDThe effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study GroupN Engl J Med199332920145614628413456
   PubMed Web of Science ®Google Scholar
• HebertLABainRPVermeDRemission of nephrotic range proteinuria in type I diabetes. Collaborative Study GroupKidney Int1994466168816937700028
   PubMed Web of Science ®Google Scholar
• PatelAADVANCE Collaborative GroupMacMahonSEffects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trialLancet2007370959082984017765963
   PubMed Web of Science ®Google Scholar
• de GalanBEPerkovicVNinomiyaTLowering blood pressure reduces renal events in type 2 diabetesJ Am Soc Nephrol200920488389219225038
   PubMed Web of Science ®Google Scholar
• AtkinsRCBrigantiEMLewisJBProteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathyAm J Kidney Dis200545228128715685505
   PubMed Web of Science ®Google Scholar
• JafarTHStarkPCSchmidCHProteinuria as a modifiable risk factor for the progression of non-diabetic renal diseaseKidney Int20016031131114011532109
   PubMed Web of Science ®Google Scholar
• ImaiEHanedaMChanJCReduction and residual proteinuria are therapeutic targets in type 2 diabetes with overt nephropathy: a post hoc analysis (ORIENT-proteinuria)Nephrol Dial Transplant201328102526253424013685
   PubMed Web of Science ®Google Scholar
• BakrisGLMangrumACopleyJBVicknairNSadlerREffect of calcium channel or beta-blockade on the progression of diabetic nephropathy in African AmericansHypertension19972937447509052890
   PubMed Web of Science ®Google Scholar
• LewisEJHunsickerLGClarkeWRRenoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetesN Engl J Med20013451285186011565517
   PubMed Web of Science ®Google Scholar
• BarnettAHBainSCBouterPAngiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathyN Engl J Med2004351191952196115516696
   PubMed Web of Science ®Google Scholar
• JacobsenPAndersenSRossingKJensenBRParvingHHDual blockade of the renin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathyKidney Int20036351874188012675866
   PubMed Web of Science ®Google Scholar
• MogensenCENeldamSTikkanenIRandomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) studyBMJ200032172741440144411110735
   PubMed Web of Science ®Google Scholar
• SongJHChaSHLeeHJEffect of low-dose dual blockade of renin-angiotensin system on urinary TGF-beta in type 2 diabetic patients with advanced kidney diseaseNephrol Dial Transplant200621368368916330466
   PubMed Web of Science ®Google Scholar
• FriedLFEmanueleNZhangJHCombined angiotensin inhibition for the treatment of diabetic nephropathyN Engl J Med2013369201892190324206457
   PubMed Web of Science ®Google Scholar
• MannJFAndersonCGaoPDual inhibition of the renin-angiotensin system in high-risk diabetes and risk for stroke and other outcomes: results of the ONTARGET trialJ Hypertens201331241442123249829
   PubMed Web of Science ®Google Scholar
• ParvingHHPerssonFLewisJBLewisEJHollenbergNKAVOID Study InvestigatorsAliskiren combined with losartan in type 2 diabetes and nephropathyN Engl J Med2008358232433244618525041
   PubMed Web of Science ®Google Scholar
• ParvingHHBrennerBMMcMurrayJJCardiorenal end points in a trial of aliskiren for type 2 diabetesN Engl J Med2012367232204221323121378
   PubMed Web of Science ®Google Scholar
• JordeUPVittorioTKatzSDColomboPCLatifFLe JemtelTHElevated plasma aldosterone levels despite complete inhibition of the vascular angiotensin-converting enzyme in chronic heart failureCirculation200210691055105712196328
   PubMed Web of Science ®Google Scholar
• SatoAHayashiKNaruseMSarutaTEffectiveness of aldosterone blockade in patients with diabetic nephropathyHypertension2003411646812511531
   PubMed Web of Science ®Google Scholar
• YoungDBSmithMJJrJacksonTEScottREMultiplicative interaction between angiotensin II and K concentration in stimulation of aldosteroneAm J Physiol19842473 Pt 1E328E3356476112
   PubMed Web of Science ®Google Scholar
• BianchiSBigazziRCampeseVMAntagonists of aldosterone and proteinuria in patients with CKD: an uncontrolled pilot studyAm J Kidney Dis2005461455115983956
   PubMed Web of Science ®Google Scholar
• RossingKSchjoedtKJSmidtUMBoomsmaFParvingHHBeneficial effects of adding spironolactone to recommended antihypertensive treatment in diabetic nephropathy: a randomized, double-masked, cross-over studyDiabetes Care20052892106211216123474
   PubMed Web of Science ®Google Scholar
• SchjoedtKJRossingKJuhlTRBeneficial impact of spironolactone in diabetic nephropathyKidney Int20056862829283616316360
   PubMed Web of Science ®Google Scholar
• van den MeirackerAHBaggenRGPauliSSpironolactone in type 2 diabetic nephropathy: Effects on proteinuria, blood pressure and renal functionJ Hypertens200624112285229217053552
   PubMed Web of Science ®Google Scholar
• MehdiUFAdams-HuetBRaskinPVegaGLTotoRDAddition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathyJ Am Soc Nephrol200920122641265019926893
   PubMed Web of Science ®Google Scholar
• RachmaniRSlavachevskyIAmitMThe effect of spironolactone, cilazapril and their combination on albuminuria in patients with hypertension and diabetic nephropathy is independent of blood pressure reduction: a randomized controlled studyDiabet Med200421547147515089793
   PubMed Web of Science ®Google Scholar
• EpsteinMWilliamsGHWeinbergerMSelective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetesClin J Am Soc Nephrol20061594095117699311
   PubMed Web of Science ®Google Scholar
• IsrailiZHHallWDCough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiologyAnn Intern Med199211732342421616218
   PubMed Web of Science ®Google Scholar
• MatcharDBMcCroryDCOrlandoLASystematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertensionAnn Intern Med20081481162917984484
   PubMed Web of Science ®Google Scholar
• IaniroGBibboSMontaltoMRicciRGasbarriniACammarotaGSystematic review: Sprue-like enteropathy associated with olmesartanAliment Pharmacol Ther2014401162324805127
   PubMed Web of Science ®Google Scholar
• StirlingCHoustonJRobertsonSDiarrhoea, vomiting and ACE inhibitors: – an important cause of acute renal failureJ Hum Hypertens200317641942312764405
   PubMed Web of Science ®Google Scholar
• YacoubRPatelNLohrJWRajagopalanSNaderNAroraPAcute kidney injury and death associated with renin angiotensin system blockade in cardiothoracic surgery: a meta-analysis of observational studiesAm J Kidney Dis20136261077108623791246
   PubMed Web of Science ®Google Scholar
• RimMYRoHKangWCThe effect of renin-angiotensin-aldosterone system blockade on contrast-induced acute kidney injury: a propensity-matched studyAm J Kidney Dis201260457658222658321
   PubMed Web of Science ®Google Scholar
• CherninGGal-OzABen-AssaESecondary prevention of hyperkalemia with sodium polystyrene sulfonate in cardiac and kidney patients on renin-angiotensin-aldosterone system inhibition therapyClin Cardiol2012351323622057933
   PubMed Web of Science ®Google Scholar